Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance. [electronic resource]
Producer: 19870930Description: 461-5 p. digitalISSN:- 0171-7111
- Amsacrine -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Child
- Clinical Trials as Topic
- Cytarabine -- administration & dosage
- Drug Administration Schedule
- Humans
- Leukemia, Lymphoid -- drug therapy
- Mercaptopurine -- administration & dosage
- Methotrexate -- administration & dosage
- Random Allocation
- Risk
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.